NM_000744.7:c.1352C>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000744.7(CHRNA4):​c.1352C>T​(p.Pro451Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00363 in 1,512,448 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P451R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0028 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 17 hom. )

Consequence

CHRNA4
NM_000744.7 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.382

Publications

10 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005767554).
BP6
Variant 20-63350059-G-A is Benign according to our data. Variant chr20-63350059-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 429 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000744.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
NM_000744.7
MANE Select
c.1352C>Tp.Pro451Leu
missense
Exon 5 of 6NP_000735.1P43681-1
CHRNA4
NM_001256573.2
c.824C>Tp.Pro275Leu
missense
Exon 5 of 6NP_001243502.1Q4VAQ3
CHRNA4
NR_046317.2
n.1561C>T
non_coding_transcript_exon
Exon 5 of 6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
ENST00000370263.9
TSL:1 MANE Select
c.1352C>Tp.Pro451Leu
missense
Exon 5 of 6ENSP00000359285.4P43681-1
CHRNA4
ENST00000463705.5
TSL:1
n.2000C>T
non_coding_transcript_exon
Exon 4 of 5
CHRNA4
ENST00000467563.3
TSL:1
n.1422C>T
non_coding_transcript_exon
Exon 5 of 6

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
429
AN:
152208
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00807
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00340
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00307
AC:
405
AN:
131754
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.000224
Gnomad AMR exome
AF:
0.000893
Gnomad ASJ exome
AF:
0.0177
Gnomad EAS exome
AF:
0.0000801
Gnomad FIN exome
AF:
0.000668
Gnomad NFE exome
AF:
0.00299
Gnomad OTH exome
AF:
0.00263
GnomAD4 exome
AF:
0.00372
AC:
5061
AN:
1360122
Hom.:
17
Cov.:
83
AF XY:
0.00388
AC XY:
2582
AN XY:
665314
show subpopulations
African (AFR)
AF:
0.000322
AC:
10
AN:
31064
American (AMR)
AF:
0.00125
AC:
40
AN:
32008
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
396
AN:
21452
East Asian (EAS)
AF:
0.0000539
AC:
2
AN:
37136
South Asian (SAS)
AF:
0.00960
AC:
682
AN:
71022
European-Finnish (FIN)
AF:
0.00104
AC:
47
AN:
45340
Middle Eastern (MID)
AF:
0.00235
AC:
12
AN:
5102
European-Non Finnish (NFE)
AF:
0.00342
AC:
3626
AN:
1060934
Other (OTH)
AF:
0.00439
AC:
246
AN:
56064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
342
684
1026
1368
1710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
429
AN:
152326
Hom.:
3
Cov.:
33
AF XY:
0.00256
AC XY:
191
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000529
AC:
22
AN:
41584
American (AMR)
AF:
0.00261
AC:
40
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00829
AC:
40
AN:
4828
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00338
AC:
230
AN:
68018
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00508
Hom.:
4
Bravo
AF:
0.00261
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000239
AC:
1
ESP6500EA
AF:
0.00242
AC:
20
ExAC
AF:
0.00270
AC:
316
Asia WGS
AF:
0.00635
AC:
22
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
4
not specified (4)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
11
DANN
Benign
0.51
DEOGEN2
Benign
0.33
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.0058
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.6
L
PhyloP100
0.38
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.14
Sift
Benign
0.21
T
Sift4G
Benign
0.14
T
Polyphen
0.0040
B
Vest4
0.15
MVP
0.74
MPC
0.41
ClinPred
0.0025
T
GERP RS
2.6
Varity_R
0.028
gMVP
0.27
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55915440; hg19: chr20-61981411; COSMIC: COSV105292768; COSMIC: COSV105292768; API